首页> HIV medicine> Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio.

Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio.

导出 LinkOut

翻译打印收藏纠错

第一作者： E,Martínez

第一单位： Hospital Clinic IDIBAPS, University of Barcelona, Barcelona, Spain.

作者： E,Martínez ^[1] ; E,Ribera ^[2] ; B,Clotet ^[3] ; V,Estrada ^[4] ; J,Sanz ^[5] ; J,Berenguer ^[6] ; R,Rubio ^[7] ; F,Pulido ^[7] ; M,Larrousse ^[8] ; A,Curran ^[2] ; E,Negredo ^[3] ; S,Arterburn ^[9] ; P,Ferrer ^[10] ; M L,Álvarez ^[10]

作者单位： Hospital Clinic IDIBAPS, University of Barcelona, Barcelona, Spain. ^[1] Hospital Universitari Vall d'Hebron, Infectious Diseases Division, Universitat Autonoma de Barcelona, Barcelona, Spain. ^[2] IrsiCaixa Foundation, Institut Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain. ^[3] Instituto de Investigación Biomédica del Hospital Clínico San Carlos, Hospital Clínico San Carlos, Madrid, Spain. ^[4] Hospital Universitario de la Princesa, Instituto de Investigación Princesa, Madrid, Spain. ^[5] Infectious Diseases/HIV Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain. ^[6] Hospital Universitario 12 de Octubre, Madrid, Spain. ^[7] Hospital de Mataró, Barcelona, Spain. ^[8] Gilead Sciences Inc., Foster City, CA, USA. ^[9] Gilead Sciences SL, Madrid, Spain. ^[10]

关键词 emtricitabine fat mass ratio lipoatrophy tenofovir zidovudine